NCT06561906 · RECRUITING
Establish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic, and Plasma Biomarkers
This study is not testing a drug or treatment. Researchers are combining brain MRI scans, memory and behavior tests, genetic information, and blood markers to build models that may spot who is more likely to slide toward mild cognitive impairment or dementia. No phase is listed. It is an observational, risk-prediction effort.
You may qualify if
- The inclusion criteria were 50-79 years old and having 8 or more years of education.
You're excluded if
- Participants with a history of stroke, other neurological disorders that could lead to cognitive impairment (Parkinson's disease, encephalitis, epilepsy, brain tumors, etc.), severe anxiety or depression, and contraindications for magnetic resonance imaging (MRI) were not enrolled.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2024-08-20